8th July 2020|Investor Media, News

Optibiotix announces major uk distribution deal with Cambridge Commodities Ltd

OptiBiotix Health PLC (‘OptiBiotix’), a leading developer of compounds to tackle obesity, cardiovascular disease and diabetes, has announced its wholly-owned subsidiary – ProBiotix Health – has partnered with Cambridge Commodities Ltd (‘CCL’) enabling the distribution of patented probiotic strain LPLDL® and dietary supplement CholBiome®X3.

The deal grants CCL, one of the UK’s leading specialty ingredients suppliers, with a non-exclusive licence to supply the flagship ingredient, LPLDL, alongside the cholesterol reducing supplement, CholBiomeX3, to businesses in the UK.

Mikkel Hvid-Hansen, Commercial Director at ProBiotix, said: “We are pleased to partner with CCL to help demonstrate an efficacious approach to managing cardiovascular health – an area of increasing importance for UK consumers. With CCL’s excellent knowledge of the UK nutraceutical industry, we hope to leverage the company’s existing expertise and further support them as one of the first movers within probiotics for heart health with our patented ingredient, LPLDL.”

Built on strong scientific principles, the probiotic Lactobacillus Plantarum LPLDL has a scientifically supported, mechanism of action that improves blood lipid profiles and blood pressure, transforming the way physical health is approached. Having demonstrated its efficacy through controlled human studies, LPLDL has been shown to reduce total cholesterol levels by up to 36.7% and systolic blood pressure by up to 5.1%, supporting greater heart health.

“As one of the core ingredients in CholBiomeX3, LPLDL has an outstanding ability to modulate bile acid metabolism to aid heart health,” adds Mikkel. “The probiotic, together with Monacolin K from red yeast rice and Vitamin B3, enables CholBiomeX3 to deliver a tri-factor approach that utilises synergistic mechanisms of action to further reduce cholesterol and aid overall cardiovascular health.

“By offering finished products, such as CholBiomeX3 through CCL, we can assist in bringing 100% guaranteed stable, safe and efficacious products to the UK market.

With over 21 years of experience in the health and wellbeing, food and beverage, and sports nutrition industries, CCL stocks more than 2,500 nutritional ingredients on its site. The company is headquartered in Cambridgeshire and employs over 100 staff to help create innovative, market-leading products.

For more information on the latest news from OptiBiotix, please visit: https://optibiotix.com/